M. KESKİNKILIÇ Et Al. , "High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)," Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, pp.851-853, 2024
KESKİNKILIÇ, M. Et Al. 2024. High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET). Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7 , 851-853.
KESKİNKILIÇ, M., SEMİZ, H. S., YAVUZŞEN, T., & KARAOĞLU, A., (2024). High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET). Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, 851-853.
KESKİNKILIÇ, MERVE Et Al. "High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)," Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, 851-853, 2024
KESKİNKILIÇ, MERVE Et Al. "High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)." Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, pp.851-853, 2024
KESKİNKILIÇ, M. Et Al. (2024) . "High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)." Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, pp.851-853.
@article{article, author={MERVE KESKİNKILIÇ Et Al. }, title={High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)}, journal={Journal of the College of Physicians and Surgeons Pakistan}, year=2024, pages={851-853} }